Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Bio Usawa Logo
Bio Usawa Growth Score
83
CB Rank
64921
Heat Score
50
Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.
Founded
obfuscation
PrivateVenture - Series Unknown San Francisco, California, United States1-10 biousawa.com
Biotechnology
Manufacturing
Medical
Pharmaceutical
Overview

Bio Usawa
Total Funding
obfuscation
Growth Score
83
Heat Score
50

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score83
-8 pts
in past quarter
Heat Score 50
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Bio Usawa

CB Rank
64921
Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.
Founded
obfuscation
PrivateVenture - Series Unknown San Francisco, California, United States1-10 biousawa.com
Biotechnology
Manufacturing
Medical
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Bio Usawa Inc.
Operating Status Active
Company Type For Profit
Phone Number +63111243423
Contact Email info@biousawa.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Monoclonal Antibody Biosimilars for Cancer
Development and manufacturing of biosimilar monoclonal antibodies targeting cancer treatment, produced affordably in Africa to improve patient access.
Monoclonal Antibody Biosimilars for Ophthalmic Diseases
Production of biosimilar monoclonal antibodies for ophthalmic conditions, aimed at providing affordable treatment options in Africa.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Bio Usawa Logo
Venture Round - Bio Usawa
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 11, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

421
-57.08%
 in past month

Active Website Tech Count

3Bio Usawa is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Bio Usawa's headquarters? Bio Usawa is located in San Francisco, California, United States.When was the last funding round for Bio Usawa? Bio Usawa closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Bio Usawa's competitors? Alternatives and possible competitors to Bio Usawa may include Pfizer, Alvotech, and  Samsung Bioepis.How much funding has Bio Usawa raised to date? Bio Usawa has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|